Author:
O’Donohoe Paul, ,Lundy J. Jason,Gnanasakthy Ari,Greene Alison
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference18 articles.
1. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Published December 2009.
2. Vodicka E, Kim K, Devine EB, et al. Inclusion of patient-reported outcome measures in registered clinical trials: evidence from clinicaltrials.gov (2007–2013). Contemp Clin Trials. 2015;43:1–9.
3. Marquis P, Caron M, Emery MP, et al. The role of health-related quality of life data in the drug approval processes in the US and Europe: a review of guidance documents and authorizations of medicinal products from 2006–2010. Pharm Med. 2011;25:147–160.
4. Bloom DE. Technology, experimentation, and the quality of survey data. Science. 1998;280:847–848.
5. Taenzer PA, Speca M, Atkinson MJ, et al. Computerized quality-of-life screening in an oncology clinic. Cancer Pract. 1997;5:168–175.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献